Casdin Partners Confirms $28.1M Stock Sale, Reduces Stake to 9.7%

summarizeSummary

Major institutional investor Casdin Partners confirmed the sale of $28.1 million worth of BioLife Solutions stock, reducing its stake to 9.7% after previously signaling intent to sell.

check_boxKey Events

• Significant Stake Reduction Confirmed

  Casdin Partners, a major institutional investor, reported the sale of 1,200,000 shares of BioLife Solutions common stock.

• $28.1 Million in Sales Executed

  The shares were sold in multiple transactions between May 19-21, 2026, for a total value of approximately $28.1 million.

• Ownership Reduced to 9.7%

  Following these sales, Casdin Partners' beneficial ownership in BioLife Solutions has decreased to 9.7% of the outstanding shares.

• Follows Prior Intent to Sell

  This Schedule 13D/A confirms the execution of sales previously indicated by multiple Form 144 filings from Casdin Partners in the days leading up to this report.

auto_awesomeAnalysis

Casdin Partners, a significant institutional investor, has reported the sale of 1.2 million shares of BioLife Solutions common stock for approximately $28.1 million. This transaction, which reduces their beneficial ownership to 9.7%, confirms the execution of sales previously indicated by a series of Form 144 filings. The substantial reduction in their position, representing over 20% of their prior holdings, signals a significant change in their investment strategy.